KR20210008828A - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- KR20210008828A KR20210008828A KR1020207020428A KR20207020428A KR20210008828A KR 20210008828 A KR20210008828 A KR 20210008828A KR 1020207020428 A KR1020207020428 A KR 1020207020428A KR 20207020428 A KR20207020428 A KR 20207020428A KR 20210008828 A KR20210008828 A KR 20210008828A
- Authority
- KR
- South Korea
- Prior art keywords
- copper
- zinc
- composition
- component
- ions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 83
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims abstract description 23
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229910001431 copper ion Inorganic materials 0.000 claims abstract description 20
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims abstract description 14
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 14
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 14
- 229960002684 aminocaproic acid Drugs 0.000 claims abstract description 13
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims abstract description 6
- 239000005749 Copper compound Substances 0.000 claims description 16
- 150000001880 copper compounds Chemical class 0.000 claims description 16
- 150000003752 zinc compounds Chemical class 0.000 claims description 14
- 239000000551 dentifrice Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 210000000214 mouth Anatomy 0.000 claims description 10
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims description 7
- 229940108925 copper gluconate Drugs 0.000 claims description 7
- 239000011592 zinc chloride Substances 0.000 claims description 5
- 235000005074 zinc chloride Nutrition 0.000 claims description 5
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 4
- 239000011670 zinc gluconate Substances 0.000 claims description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims description 4
- 229960000306 zinc gluconate Drugs 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 claims description 3
- 229940079841 sodium copper chlorophyllin Drugs 0.000 claims description 3
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 claims description 3
- 229960001939 zinc chloride Drugs 0.000 claims description 2
- 206010006326 Breath odour Diseases 0.000 abstract description 36
- 238000002156 mixing Methods 0.000 abstract description 19
- 208000032139 Halitosis Diseases 0.000 abstract description 17
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 15
- 230000002401 inhibitory effect Effects 0.000 abstract description 10
- 238000002845 discoloration Methods 0.000 description 25
- 238000009472 formulation Methods 0.000 description 23
- 230000000694 effects Effects 0.000 description 21
- -1 etc. Substances 0.000 description 19
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 8
- 230000002688 persistence Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 229910052802 copper Inorganic materials 0.000 description 6
- 239000010949 copper Substances 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 230000002045 lasting effect Effects 0.000 description 6
- 208000028169 periodontal disease Diseases 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000000606 toothpaste Substances 0.000 description 5
- 229940034610 toothpaste Drugs 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000003082 abrasive agent Substances 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- JVOGSHDZLOJKKR-MXFMKSRJSA-I [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O Chemical compound [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O JVOGSHDZLOJKKR-MXFMKSRJSA-I 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical class [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- MVOSYKNQRRHGKX-UHFFFAOYSA-N 11-Undecanolactone Chemical compound O=C1CCCCCCCCCCO1 MVOSYKNQRRHGKX-UHFFFAOYSA-N 0.000 description 1
- HVNMCCPQUIEPCT-UHFFFAOYSA-N 2-(dimethylazaniumyl)pentanoate Chemical compound CCCC(N(C)C)C(O)=O HVNMCCPQUIEPCT-UHFFFAOYSA-N 0.000 description 1
- CFAKWWQIUFSQFU-UHFFFAOYSA-N 2-hydroxy-3-methylcyclopent-2-en-1-one Chemical compound CC1=C(O)C(=O)CC1 CFAKWWQIUFSQFU-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- TWXUTZNBHUWMKJ-UHFFFAOYSA-N Allyl cyclohexylpropionate Chemical compound C=CCOC(=O)CCC1CCCCC1 TWXUTZNBHUWMKJ-UHFFFAOYSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000010631 citron oil Substances 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 229940079721 copper chloride Drugs 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 229960000355 copper sulfate Drugs 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 229940093928 potassium nitrate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- AYGJDUHQRFKLBG-UHFFFAOYSA-M sodium;1,1-dioxo-1,2-benzothiazol-3-olate;dihydrate Chemical group O.O.[Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 AYGJDUHQRFKLBG-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DUYAAUVXQSMXQP-UHFFFAOYSA-M thioacetate Chemical compound CC([S-])=O DUYAAUVXQSMXQP-UHFFFAOYSA-M 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 150000003623 transition metal compounds Chemical class 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
항염증 성분인 트라넥삼산 또는 ε-아미노카프론산을 안정적으로 배합하고, 또한 우수한 구취억제 효과를 부여하는 구강용 조성물을 제공한다. (A) 트라넥삼산 또는 ε-아미노카프론산, (B) 구리 이온 또는 아연 이온, 및 (C) 모노플루오로인산 나트륨을 함유하며, (C)성분 함유량이 0.8~3질량%인 구강용 조성물.It provides an oral composition stably blending tranexamic acid or ε-aminocaproic acid, which is an anti-inflammatory component, and imparting an excellent halitosis inhibitory effect. Oral composition containing (A) tranexamic acid or ε-aminocaproic acid, (B) copper ions or zinc ions, and (C) sodium monofluorophosphate, and (C) having a component content of 0.8 to 3% by mass .
Description
본 발명은 항염증 성분의 트라넥삼산 또는 ε-아미노카프론산이 안정적으로 배합되며, 또한 우수한 구취억제 효과를 부여하는 구강용 조성물에 관한 것이다.The present invention relates to a composition for oral cavity in which tranexamic acid or ε-aminocaproic acid as an anti-inflammatory component is stably blended, and provides an excellent halitosis inhibitory effect.
치주병은 구취를 수반하는 경우가 많아, 잇몸 케어를 목적으로 하는 구강용 조성물에 상기 항염증 성분과 함께 구취억제에 유효한 약효 성분을 배합해서 양자의 작용 효과를 부여하는 것은, 치주병의 예방 또는 억제에 효과적이며 바람직하다.Periodontal disease is often accompanied by bad breath, and the anti-inflammatory component and a medicinal ingredient effective for suppressing bad breath are added to an oral composition for the purpose of gum care to impart both effects to prevent periodontal disease or It is effective and desirable for inhibition.
항염증 작용을 갖는 트라넥삼산이나 ε-아미노카프론산은, 염증성의 질환인 치주병의 예방 대책용 치마제 등의 구강용 조성물에 사용되는 항염증 성분이지만, 구강용 조성물의 배합 성분에 따라서는 안정성이 나빠져 시간 경과로 제제 변색을 초래할 경우가 있고, 또한, 타성분을 용이하게 첨가할 수 없어 다른 구취억제 성분을 병용하는 것이 어려웠다.Tranexamic acid and ε-aminocaproic acid, which have anti-inflammatory effects, are anti-inflammatory components used in oral compositions such as dentifrice for preventing periodontal disease, which is an inflammatory disease, but depending on the composition of the oral composition, The stability may deteriorate and discoloration of the formulation may be caused over time, and other ingredients cannot be easily added, making it difficult to use other bad breath suppressing ingredients in combination.
특허문헌 1(일본 특허 제 5842565호 공보)에서는, 트라넥삼산 또는 ε-아미노카프론산과, 신남알데히드 및 알킬황산염을 배합하여 액체 구강용 조성물의 제제 변색을 억제하고 있다.In Patent Document 1 (Japanese Patent No. 5842565), tranexamic acid or ε-aminocaproic acid, cinnamic aldehyde and an alkyl sulfate are blended to suppress discoloration of a liquid oral composition.
그런데, 구리나 아연에는 치주병 원인균으로부터 발생하는 휘발성 황 화합물(VSC)을 억제하는 작용이 있어, 구리 또는 아연 이온을 공급하는 수용성의 구리 또는 아연 화합물은 구취억제 작용을 갖는 성분으로서 알려져 있지만, 이것들의 구취억제 지속 효과는 충분하다고는 할 수 없는 것이었다.By the way, copper or zinc has an action of inhibiting volatile sulfur compounds (VSC) generated from periodontal disease causative bacteria, and water-soluble copper or zinc compounds that supply copper or zinc ions are known as components having a bad breath inhibiting action. The lasting effect of halitosis suppression was not sufficient.
특허문헌 2, 3(일본 특허 제 2580657호 공보, 일본 특허 제 2738021호 공보)에서는 글루콘산 구리, 시트르산 구리 등의 수용성 구리 화합물에, 다염기산이나 개질 수산화알루미늄을 병용함으로써 구취 방지 효과를 향상시킬 수 있는 것이 제안되어 있다.In Patent Documents 2 and 3 (Japanese Patent No. 2580657, Japanese Patent No. 2738021), a polybasic acid or modified aluminum hydroxide can be used in combination with a water-soluble copper compound such as copper gluconate and copper citrate to improve the effect of preventing bad breath. Is proposed.
본 발명은 상기 사정을 감안하여 이루어진 것으로, 항염증 성분의 트라넥삼산 또는 ε-아미노카프론산을 안정적으로 배합하며, 또한 우수한 구취억제 지속 효과를 부여하는 구강용 조성물을 제공하는 것을 목적으로 한다.The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a composition for oral cavity stably blending tranexamic acid or ε-aminocaproic acid as an anti-inflammatory component and providing an excellent lasting effect of suppressing bad breath.
본 발명자들은 상기 목적을 달성하기 위해 예의 검토를 행한 결과, 항염증 성분인 (A) 트라넥삼산 또는 ε-아미노카프론산에, 구취억제 성분으로서 (B) 구리 이온 또는 아연 이온, 바람직하게는 상기 이온의 공급원으로서 수용성의 구리 화합물 또는 아연 화합물을 병용하고, 또한 (C) 모노플루오로인산 나트륨을 특정량으로 조합시켜서 구강용 조성물에 배합하면, (A)성분에 유래하는 제제 변색이 보존 후에도 억제되고, 또한 구취억제 효과가 사용 직후로부터 수시간 경과 후에도 지속되어, (A)성분을 안정적으로 배합할 수 있음과 아울러 우수한 구취억제 효과를 부여할 수 있는 것을 지견하여 본 발명을 이루기에 이르렀다.The inventors of the present invention conducted a thorough study in order to achieve the above object, and as a result of the anti-inflammatory component (A) tranexamic acid or ε-aminocaproic acid, and (B) copper ions or zinc ions as the halitosis suppressing component, preferably the above When a water-soluble copper compound or zinc compound is used in combination as a source of ions, and (C) sodium monofluorophosphate is combined in a specific amount and blended into an oral composition, discoloration of the formulation derived from (A) component is suppressed even after storage. In addition, it was discovered that the halitosis suppressing effect persisted even after several hours from immediately after use, and that the component (A) could be stably blended and an excellent halitosis suppressing effect could be imparted, and the present invention was accomplished.
더욱 상세히 설명하면, 항염증 작용을 갖는 (A)성분에 구취억제 작용을 갖는 (B)성분을 병용해서 구강용 조성물에 배합해도, 구취억제 효과가 지속되지 않아, 사용해서 수시간 경과되면 거의 확인되지 않게 되며(후술의 비교예 6 참조), 또한 구취억제 지속 효과를 향상시키기 위해 (B)성분을 증량하면, (A)성분 유래의 제제 변색이 야기된다는 제제 안정성 상의 문제가 발생했다(후술의 비교예 5 참조). 그래서, 상기 구취억제 및 제제 변색에 관한 문제를 해소하기 위해, 본 발명자들이 더욱 검토를 진행한 바, (C)성분을 특정량으로 더 첨가하면, 상기 문제가 해소되어 제제 변색을 보존 후에도 억제하고, 또한 (B)성분을 비교적 많은 양으로 배합하지 않아도 구취억제 효과를 지속시킬 수 있었다. 그리고, 이것에 의해, (A)성분에 의한 항염증 효과에 추가해서, 사용 후에도 수시간 지속되는 우수한 구취억제 효과를 부여하는 것이 가능해졌다. 이 경우, (A) 및 (B)성분에 (C)성분을 병용해도, (C)성분량이 비교적 적고 부적절량이면 제제 변색이 확인되었지만(후술의 비교예 1, 2 참조), (C)성분의 첨가량이 특정값 이상이면, 의외로, (C)성분에 의해 제제 변색이 억제되어, 장기간 보존 후에도 제제 변색이 거의 확인되는 경우가 없었다(후술의 실시예 참조). 따라서, 본 발명에 의하면, (A)성분 및 (B)성분을 동시에 배합하여 상기 각별한 작용 효과를 부여할 수 있다.In more detail, even if the component (B) which has anti-inflammatory action and component (B) which has an anti-inflammatory action are used in combination in an oral composition, the anti-odor effect does not persist, and it is almost confirmed after several hours of use. (See Comparative Example 6 described later). Further, when the (B) component is increased in order to improve the lasting effect of halitosis, there has been a problem in the formulation stability that discoloration of the formulation derived from the component (A) is caused (described later). See Comparative Example 5). Therefore, in order to solve the problem related to the suppression of bad breath and discoloration of the formulation, the present inventors further studied.When the component (C) is further added in a specific amount, the above problem is solved and discoloration of the formulation is suppressed even after storage. In addition, even if the component (B) was not mixed in a relatively large amount, the effect of suppressing bad breath could be sustained. And by this, in addition to the anti-inflammatory effect of the component (A), it became possible to impart an excellent halitosis suppressing effect lasting several hours even after use. In this case, even if the (C) component was used in combination with the (A) and (B) components, discoloration of the formulation was confirmed when the (C) component amount was relatively small and an inappropriate amount (refer to Comparative Examples 1 and 2 described later), (C) component When the addition amount of is not less than a specific value, unexpectedly, discoloration of the formulation was suppressed by the component (C), and discoloration of the formulation was hardly observed even after long-term storage (see Examples to be described later). Therefore, according to the present invention, the above-described special effects can be provided by simultaneously blending the component (A) and the component (B).
본 발명의 작용 효과는, 예를 들면 후술의 비교예 4에 나타내는 바와 같이 (C)성분 대신에 인산 수소2나트륨을 사용하면 구취억제 지속 효과가 떨어지고, 또한, (C)성분 대신에 그 이외의 불소 함유 화합물을 사용했을 경우, 또는 (B)성분 대신에 물에 난용성인 시트르산 구리를 사용했을 경우에도, 본 발명의 효과가 떨어지는 것이었다. 이것에 대하여, 실시예에 나타내는 본 발명의 (A), (B) 및 (C)성분을 함유하고, (C)성분의 함유량이 특정 범위 내인 구강용 조성물은, 제제 변색이 보존 후에도 억제되어서 변색의 없음이 우수하고, 또한 구취억제 효과(직후) 및 그 지속성(3시간 경과 후)이 우수한 것이었다.The effect of the present invention is, for example, as shown in Comparative Example 4 described later, if disodium hydrogen phosphate is used instead of the component (C), the lasting effect of suppressing bad breath is inferior, and, in place of the component (C), When a fluorine-containing compound is used, or when copper citrate which is poorly soluble in water is used instead of the component (B), the effect of the present invention is inferior. On the other hand, the composition for oral cavity containing the components (A), (B) and (C) of the present invention shown in the examples, and the content of the component (C) is within a specific range, discoloration of the formulation is suppressed even after storage It was excellent in the absence of a bad breath, and the effect of suppressing bad breath (immediately after) and its persistence (after 3 hours) were excellent.
또, 특허문헌 4(일본 특허 제 3922329호 공보)는, 축합 인산염 등과 수용성 전이금속 화합물을 함유하는 치마제 조성물의 수렴성이나 금속미를, 아미노산에 의한 변색을 방지하면서 개선한 발명으로, 구취억제 효과에 착안하고 있지 않고 어떠한 언급도 없다.In addition, Patent Document 4 (Japanese Patent No. 3922329) is an invention in which the astringent and metallic taste of a dentifrice composition containing a condensed phosphate or the like and a water-soluble transition metal compound is improved while preventing discoloration by amino acids. It does not focus on and does not mention any.
따라서, 본 발명은 하기의 구강용 조성물을 제공한다.Therefore, the present invention provides the following oral composition.
〔1〕〔One〕
(A) 트라넥삼산 또는 ε-아미노카프론산,(A) tranexamic acid or ε-aminocaproic acid,
(B) 구리 이온 또는 아연 이온, 및(B) copper ions or zinc ions, and
(C) 모노플루오로인산 나트륨(C) sodium monofluorophosphate
을 함유하고, (C)성분의 함유량이 0.8∼3질량%인 구강용 조성물.A composition for oral cavity containing, and the content of (C) component is 0.8-3 mass %.
〔2〕〔2〕
(B) 구리 이온 또는 아연 이온의 공급원이, 25℃에 있어서의 수용해도가 5g/100mL 이상인 수용성의 구리 화합물 또는 아연 화합물인 〔1〕에 기재된 구강용 조성물.(B) The oral composition according to [1], wherein the source of the copper ion or zinc ion is a water-soluble copper compound or zinc compound having a water solubility at 25°C of 5 g/100 mL or more.
〔3〕(3)
(B) 구리 이온 또는 아연 이온의 공급원이, 글루콘산 구리, 구리클로로필린 나트륨, 염화아연 및 글루콘산 아연으로부터 선택되는 1종 또는 2종 이상의 수용성의 구리 화합물 또는 아연 화합물인 〔1〕 또는 〔2〕에 기재된 구강용 조성물.(B) [1] or [2] wherein the source of the copper ion or zinc ion is one or two or more water-soluble copper compounds or zinc compounds selected from copper gluconate, sodium copper chlorophyllin, zinc chloride and zinc gluconate. The oral composition according to [].
〔4〕〔4〕
(B) 구리 이온 또는 아연 이온의 공급원이, 25℃에 있어서의 수용해도가 5g/100mL 미만인 수난용성 또는 수불용성의 구리 화합물 또는 아연 화합물의 산성수용액인 〔1〕에 기재된 구강용 조성물.(B) The oral composition according to [1], wherein the supply source of copper ions or zinc ions is an acidic aqueous solution of a poorly water-soluble or water-insoluble copper compound or zinc compound having a water solubility at 25°C of less than 5 g/100 mL.
〔5〕(5)
(A)성분을 0.006∼0.5질량%, (B)성분을 0.001∼0.1질량% 함유하는 〔1〕∼ 〔4〕 중 어느 하나에 기재된 구강용 조성물.The oral composition according to any one of [1] to [4], containing 0.006 to 0.5 mass% of the component (A) and 0.001 to 0.1 mass% of the component (B).
〔6〕(6)
(C)/(B)가 질량비로서 10∼1,500인 〔1〕∼〔5〕 중 어느 하나에 기재된 구강용 조성물.The oral composition according to any one of [1] to [5], wherein (C)/(B) is 10 to 1,500 as a mass ratio.
〔7〕(7)
치마제 조성물인 〔1〕∼〔6〕 중 어느 하나에 기재된 구강용 조성물.The oral composition according to any one of [1] to [6] which is a dentifrice composition.
본 발명에 의하면, 항염증 성분의 트라넥삼산 또는 ε-아미노카프론산을 안정적으로 배합하며, 또한 구취억제 효과가 사용 직후로부터 수시간 경과 후에도 지속되는 우수한 구취억제 효과를 부여하는 구강용 조성물을 제공할 수 있다. 상기 구강용 조성물은 치주병의 예방 또는 억제용으로서 유효하게 사용할 수 있다.According to the present invention, there is provided a composition for oral cavity that stably blends tranexamic acid or ε-aminocaproic acid as an anti-inflammatory component, and provides an excellent halitosis suppressing effect lasting several hours from immediately after use. can do. The oral composition can be effectively used for preventing or inhibiting periodontal disease.
이하, 본 발명에 대하여 더욱 상세히 설명한다. 본 발명의 구강용 조성물은 (A) 트라넥삼산 또는 ε-아미노카프론산, (B) 구리 이온 또는 아연 이온, (C) 모노플루오로인산 나트륨을 함유한다. 상기 「구리 이온 또는 아연 이온」은, 조성물의 액체 매체(물 등) 중에 용해되어 있는 구리 화합물이나 아연 화합물의 구리 이온이나 아연 이온을 의미하며, 조성물 중에 고체 형상으로 존재하는 불용의 구리 화합물, 아연 화합물은 아니다.Hereinafter, the present invention will be described in more detail. The oral composition of the present invention contains (A) tranexamic acid or ε-aminocaproic acid, (B) copper ions or zinc ions, and (C) sodium monofluorophosphate. The ``copper ions or zinc ions'' refer to copper ions or zinc ions of a copper compound or zinc compound dissolved in a liquid medium (water, etc.) of the composition, and an insoluble copper compound or zinc present in a solid form in the composition Not a compound.
(A) 트라넥삼산 또는 ε-아미노카프론산은 항염증 작용을 갖는 유효 성분이다. (A)성분은 트라넥삼산, ε-아미노카프론산을 사용할 수 있지만, 트라넥삼산 및 ε-아미노카프론산을 병용할 수도 있다.(A) Tranexamic acid or ε-aminocaproic acid is an active ingredient having anti-inflammatory action. Tranexamic acid and ε-aminocapronic acid can be used as the component (A), but tranexamic acid and ε-aminocaproic acid can also be used in combination.
(A)성분의 배합량은 조성물 전체의 0.006∼0.5%(질량%, 이하 동일)가 바람직하고, 보다 바람직하게는 0.03∼0.2%이다. 배합량이 많을수록 항염증 효과가 높아지고, 0.006% 이상이면 충분한 항염증 효과가 얻어진다. 0.5% 이하이면 제제 변색이 충분히 억제되며, 또한 (A)성분 자체에 의한 자극의 발현을 충분히 방지할 수 있다.The blending amount of the component (A) is preferably 0.006 to 0.5% (mass%, hereinafter the same) of the whole composition, more preferably 0.03 to 0.2%. The larger the blending amount, the higher the anti-inflammatory effect, and if it is 0.006% or more, a sufficient anti-inflammatory effect is obtained. If it is 0.5% or less, discoloration of the formulation is sufficiently suppressed, and the expression of irritation caused by the component (A) itself can be sufficiently prevented.
(B)성분은 구리 이온 또는 아연 이온이다.(B) The component is a copper ion or a zinc ion.
본 발명의 구강용 조성물 중에 용해되어 있는 구리 이온 또는 아연 이온은 구취억제 작용을 갖는 성분이다. (B)성분으로서는, 상기 구리 이온 또는 아연 이온을 단독 사용, 또는 양쪽 이온을 병용할 수 있다.Copper ions or zinc ions dissolved in the oral composition of the present invention are components having a bad breath suppressing effect. As (B) component, the said copper ion or zinc ion can be used individually, or both ions can be used together.
(B)성분은 수용성 화합물 유래라고 할 수 있고, 상기 이온의 공급원으로서 수용성의 구리 화합물, 아연 화합물을 사용하여 배합할 수 있다. 여기에서의 수용성 화합물이란, 25℃에 있어서의 수용해도가 5g/100mL 이상인 화합물이다. 이와 같은 수용성 구리 화합물은, 예를 들면 글루콘산 구리, 황산 구리, 염화구리, 구리 클로로필린나트륨, 아세트산 구리를 들 수 있다. 수용성 아연 화합물은 염화아연, 황산 아연, 질산 아연, 글루콘산 아연을 들 수 있다. 이것들은 1종 단독으로 또는 2종 이상을 조합시켜서 사용할 수 있지만, 그 중에서도 글루콘산 구리, 구리클로로필린나트륨, 염화아연, 글루콘산 아연이 바람직하고, 보다 바람직하게는 수용성 구리 화합물의 글루콘산 구리, 구리클로로필린나트륨이다.The component (B) can be said to be derived from a water-soluble compound, and can be blended using a water-soluble copper compound or a zinc compound as the source of the ion. The water-soluble compound herein is a compound having a water solubility of 5 g/100 mL or more at 25°C. Examples of such a water-soluble copper compound include copper gluconate, copper sulfate, copper chloride, sodium copper chlorophyllin, and copper acetate. The water-soluble zinc compound includes zinc chloride, zinc sulfate, zinc nitrate, and zinc gluconate. These can be used alone or in combination of two or more, but among them, copper gluconate, copper chlorophyllin sodium, zinc chloride, zinc gluconate are preferable, more preferably copper gluconate of a water-soluble copper compound, It is copper chlorophyllin sodium.
(B)성분은 다른 형태로서 수난용성 또는 불용성의 구리 화합물, 아연 화합물을 다른 용매에 용해한 용액 유래의 구리 이온, 아연 이온을 사용할 수도 있고, 상기 용액을 이온의 공급원으로서 사용하여 배합할 수도 있다. 예를 들면, 수불용성의 산화구리나 산화아연을 희염산 등의 산성 수용액에 용해해서 얻어진 구리 이온, 아연 이온을 사용할 수도 있다. 또한, 금속 착체를 형성시켜서 계 중에 용해시켜도 좋다. 여기에서, 「수난용성 또는 불용성」은 25℃에 있어서의 수용해도가 5g/100mL 미만인 것을 의미한다.As for the component (B), as another form, a poorly water-soluble or insoluble copper compound, copper ions and zinc ions derived from a solution obtained by dissolving a zinc compound in another solvent may be used, or the above solution may be used as a source of ions and blended. For example, copper ions and zinc ions obtained by dissolving water-insoluble copper oxide or zinc oxide in an acidic aqueous solution such as dilute hydrochloric acid can also be used. Further, a metal complex may be formed and dissolved in the system. Here, "poorly water soluble or insoluble" means that the water solubility at 25°C is less than 5 g/100 mL.
(B)성분의 배합량은 구리 이온, 아연 이온량으로서, 조성물 전체의 0.001∼0.1%가 바람직하고, 보다 바람직하게는 0.005∼0.05%이다. 배합량이 0.001% 이상이면 구취억제 효과 및 그 지속성이 충분히 얻어지고, 0.1% 이하이면 제제 변색이 충분히 억제된다.The blending amount of the component (B) is the amount of copper ions and zinc ions, preferably 0.001 to 0.1% of the total composition, and more preferably 0.005 to 0.05%. When the blending amount is 0.001% or more, the halitosis suppressing effect and its persistence are sufficiently obtained, and when it is 0.1% or less, discoloration of the formulation is sufficiently suppressed.
(B)성분으로서는, 상기 (B)성분의 배합량의 범위를 만족시키는 양으로, 상기 구리 화합물, 아연 화합물을 배합하는 것이 바람직하고, 이 경우, 상기 구리 화합물, 아연 화합물의 배합량은, 조성물 전체의 0.01∼0.5%, 특히 0.05∼0.3%가 바람직하다.As the component (B), it is preferable to blend the copper compound and the zinc compound in an amount satisfying the range of the blending amount of the component (B). In this case, the blending amount of the copper compound and the zinc compound is It is preferably 0.01 to 0.5%, particularly 0.05 to 0.3%.
(C) 모노플루오로인산 나트륨은 충치 예방의 유효 성분으로서 이미 알려져 있지만, 본 발명에서는 소정 농도 이상 배합함으로써, (A) 및 (B)성분의 병용계에 의한 제제 변색을 억제하는 작용을 이루고, 또한, 구취억제 효과의 지속성을 향상시키는 작용을 이룬다. 또, (C)성분 이외의 불소 함유 화합물, 예를 들면 불화나트륨을 사용하면, 제제 변색이 억제되지 않아 본 발명의 작용 효과가 떨어진다.(C) Sodium monofluorophosphate is already known as an active ingredient for preventing tooth decay, but in the present invention, by blending at a predetermined concentration or more, it has an action of suppressing discoloration of the formulation due to the combination system of the components (A) and (B), In addition, it serves to improve the persistence of the halitosis inhibitory effect. Further, when a fluorine-containing compound other than the component (C), for example sodium fluoride, is used, discoloration of the formulation is not suppressed, and the effect of the present invention is inferior.
(C)성분의 배합량은 조성물 전체의 0.8∼3%이며, 바람직하게는 1∼2%, 특히 1∼1.5%이다. 배합량이 0.8%에 충족되지 않으면 제제 변색의 억제 효과가 떨어진다. 배합량이 많을수록 제제 변색이 억제되고, 또한 구취억제 효과의 지속성이 높아지지만, 3%를 초과하면 (C)성분 자체에 의한 떫은맛, 쓴맛이 발현되어 사용에 적합하지 않게 된다.The blending amount of the component (C) is 0.8 to 3% of the total composition, preferably 1 to 2%, particularly 1 to 1.5%. If the blending amount is not satisfied at 0.8%, the inhibitory effect of discoloration of the formulation is inferior. The higher the blending amount, the more the discoloration of the formulation is suppressed, and the persistence of the halitosis suppressing effect increases, but if it exceeds 3%, the astringent taste and bitter taste due to the component (C) itself are expressed, making it unsuitable for use.
본 발명에 있어서, (B)성분량(구리 이온, 아연 이온량)과 (C)성분량의 비율을 나타내는 (C)/(B)는 특별하게 한정되지 않지만, 질량비로서 10∼1,500이 바람직하고, 보다 바람직하게는 35∼1,100, 더 바람직하게는 35∼150이다. 상기 범위 내이면, 제제 변색의 억제 효과가 보다 우수하며, 구취억제 효과 및 그 지속성도 우수하다. (C)/(B)의 질량비가 10에 미치지 않으면, 제제 변색의 억제 효과가 충분히 얻어지지 않을 경우가 있고, 1,500을 초과하면, 구취억제 효과의 지속성이 충분히 얻어지지 않을 경우가 있다.In the present invention, (C)/(B) representing the ratio of the (B) component amount (the amount of copper ions and zinc ions) and (C) the component amount is not particularly limited, but the mass ratio is preferably 10 to 1,500, more preferably. It is preferably 35 to 1,100, more preferably 35 to 150. If it is within the above range, the discoloration inhibitory effect of the formulation is more excellent, and the halitosis inhibitory effect and its persistence are also excellent. When the mass ratio of (C)/(B) is less than 10, the effect of suppressing discoloration of the formulation may not be sufficiently obtained, and when it exceeds 1,500, the persistence of the halitosis suppressing effect may not be sufficiently obtained.
본 발명의 구강용 조성물은 치약, 액체 치약 등의 치마제, 구강 세정제, 도포제, 스프레이제, 첩부제, 추잉검, 구미와 같은 다양한 제형으로 조제 가능하지만, 바람직하게는 치마제, 구강 세정제, 도포제, 특히 치마제, 그 중에서도 치약제로 조제되고, 치마제 조성물인 것이 보다 바람직하다. 또한, 상기 구강용 조성물은 제형에 따른 상법을 채용해서 조제할 수 있다. 이 경우, 조성물의 목적, 제형 등에 따라, 상기 성분에 추가해서 그 밖의 공지 성분을 임의로 배합할 수 있다. 예를 들면, 치약제의 경우에는, 연마제, 점조제, 점결제, 계면활성제, 또한, 필요에 의해 감미제, 방부제, 착색제, 향료나, (A), (B) 및 (C)성분 이외의 유효 성분을 배합할 수 있고, 이들 성분과 물을 혼합하여 제조할 수 있다.The composition for oral cavity of the present invention can be prepared in various formulations such as dentifrice, liquid toothpaste, etc., mouthwash, coating agent, spray, patch, chewing gum, gummi, but preferably dentifrice, mouthwash, coating agent , In particular, it is prepared with a dentifrice, especially a toothpaste, and is more preferably a dentifrice composition. In addition, the oral composition can be prepared by employing a commercial method according to the formulation. In this case, in addition to the above components, other known components may be optionally blended depending on the purpose of the composition, formulation, and the like. For example, in the case of toothpaste, active ingredients other than abrasives, viscous agents, binders, surfactants, sweeteners, preservatives, coloring agents, flavoring agents, and (A), (B) and (C) components as needed Can be blended, and can be prepared by mixing these components and water.
연마제는 침강성 실리카, 알루미노실리케이트, 지르코노실리케이트 등의 실리카계 연마제, 제 2 인산 칼슘·2수화물 또는 무수화물, 제 1 인산 칼슘, 제 3 인산 칼슘 등의 인산 칼슘계 연마제, 탄산 칼슘, 수산화알루미늄을 들 수 있다. 연마제의 배합량은 조성물 전체의 0∼50%, 특히 5∼30%가 바람직하다.Abrasives include silica-based abrasives such as precipitated silica, aluminosilicate, and zirconosilicate, calcium phosphate abrasives such as dicalcium phosphate, dihydrate or anhydride, calcium phosphate, calcium phosphate, calcium carbonate, and aluminum hydroxide. Can be mentioned. The blending amount of the abrasive is preferably 0 to 50%, particularly 5 to 30% of the total composition.
점조제는 소르비톨, 크실리톨, 에리스리톨 등의 당알콜, 글리세린, 프로필렌글리콜 등의 다가 알콜을 들 수 있다. 점조제의 배합량은 조성물 전체의 5∼60%, 특히 20∼50%가 바람직하다.Examples of the viscosity aid include sugar alcohols such as sorbitol, xylitol, and erythritol, and polyhydric alcohols such as glycerin and propylene glycol. The blending amount of the viscous agent is preferably 5 to 60%, particularly 20 to 50% of the total composition.
점결제는 유기 또는 무기 점결제를 배합할 수 있다. 구체적으로 유기 점결제는, 카르복시메틸셀룰로오스나트륨, 메틸셀룰로오스 등의 셀룰로오스 유도체, 크산탄검, 아라비아검 등의 검류, 알긴산 유도체, 카라기난, 무기 점결제는 겔화성 실리카, 겔화성 알루미늄실리카, 비검, 라포나이트를 들 수 있다. 점결제의 배합량은 제형에 따라 조정할 수 있고, 치약의 경우, 유기 점결제는 조성물 전체의 0.1∼5%, 특히 0.5∼3%가 좋고, 무기 점결제는 조성물 전체의 1∼10%, 특히 2∼8%가 좋다. 액체 제제의 구강 세정제에서는, 유기 점결제, 무기 점결제 모두 각각 조성물 전체의 0∼5%가 좋다.The binder may contain an organic or inorganic binder. Specifically, organic binders include cellulose derivatives such as sodium carboxymethylcellulose and methylcellulose, gums such as xanthan gum and gum arabic, alginic acid derivatives, carrageenan, and inorganic binders: gelatinous silica, gelatinous aluminum silica, bigum, rapo There is a knight. The blending amount of the binder can be adjusted according to the formulation, and in the case of toothpaste, the organic binder is preferably 0.1 to 5%, particularly 0.5 to 3% of the composition, and the inorganic binder is 1 to 10%, particularly 2 ∼8% is good. In the oral detergent of a liquid formulation, 0-5% of the whole composition is good for both an organic caking agent and an inorganic caking agent.
계면활성제로서는 음이온성 계면활성제, 비이온성 계면활성제, 양이온성 계면활성제, 양성 계면활성제를 배합할 수 있다.As surfactants, anionic surfactants, nonionic surfactants, cationic surfactants, and amphoteric surfactants can be blended.
음이온성 계면활성제는 라우릴황산 나트륨 등의 알킬황산염, 아실아미노산염, 아실타우린염 등을 들 수 있다.Examples of the anionic surfactant include alkyl sulfates such as sodium lauryl sulfate, acylamino acid salts, and acyltaurine salts.
비이온성 계면활성제는 수크로오스 지방산 에스테르 등의 당 지방산 에스테르, 당알콜 지방산 에스테르, 소르비탄 지방산 에스테르, 글리세린 지방산 에스테르, 폴리글리세린 지방산 에스테르나, 폴리옥시에틸렌소르비탄 지방산 에스테르, 폴리옥시에틸렌 경화 피마자유 등의 폴리옥시에틸렌 지방산 에스테르, 폴리옥시에틸렌 고급 알콜에테르를 들 수 있다.Nonionic surfactants include sugar fatty acid esters such as sucrose fatty acid esters, sugar alcohol fatty acid esters, sorbitan fatty acid esters, glycerin fatty acid esters, polyglycerol fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene hydrogenated castor oil, and the like. Oxyethylene fatty acid ester and polyoxyethylene higher alcohol ether.
양이온성 계면활성제는 알킬암모늄염을 들 수 있고, 양성 계면활성제는 알킬 베타인, 지방산 아미드알킬 베타인, 지방산 아미드프로필디메틸아미노아세트산 베타인을 들 수 있다.Cationic surfactants include alkyl ammonium salts, and amphoteric surfactants include alkyl betaine, fatty acid amide alkyl betaine, and fatty acid amide propyldimethylaminoacetic acid betaine.
계면활성제의 배합량은 조성물 전체의 0∼10%, 특히 0.1∼5%가 좋다.The blending amount of the surfactant is preferably 0 to 10%, particularly 0.1 to 5% of the total composition.
감미제는 사카린나트륨, 방부제는 파라옥시벤조산 에스테르, 벤조산 또는 그 염을 들 수 있다.The sweetening agent is sodium saccharin, and the preservative is paraoxybenzoic acid ester, benzoic acid, or its salt.
착색제는 청색 1호, 황색 4호, 이산화티탄을 들 수 있다.The colorants include Blue No. 1, Yellow No. 4, and titanium dioxide.
향료는 페퍼민트유, 스피어민트유, 아니스유, 유칼리유, 원터그린유, 카시아유, 클로브유, 타임유, 세이지유, 레몬유, 오렌지유, 박하유, 카르다몬유, 코리앤더유, 만다린유, 라임유, 라벤더유, 로즈메리유, 월계수유, 캐모마일유, 캐러웨이유, 마조람유, 베이유, 레몬그라스유, 오리가남유, 파인니들유, 네롤리유, 로즈유, 재스민유, 그레이프후르츠유, 스위티유, 유자유, 아이리스 콘크리트, 앱솔루트 페퍼민트, 앱솔루트 로즈, 오렌지플라워 등의 천연 향료나, 이들 천연 향료의 가공 처리(전류부(前溜部) 커트, 후류부 커트, 분류, 액액 추출, 에센스화, 분말 향료화 등)한 향료, 및 멘톨, 카르본, 아네톨, 시네올, 살리실산 메틸, 신남알데히드, 오이게놀, 3-1-멘톡시프로판-1,2-디올, 티몰, 리날로올, 리날릴아세테이트, 리모넨, 멘톤, 멘틸아세테이트, N-치환-파라멘탄-3-카르복사미드, 피넨, 옥틸알데히드, 시트랄, 풀레곤, 카르빌아세테이트, 아니스알데히드, 에틸아세테이트, 에틸부티레이트, 알릴시클로헥산프로피오네이트, 메틸안트라닐레이트, 에틸메틸페닐글리시데이트, 바닐린, 운데카락톤, 헥산알, 부탄올, 이소아밀알콜, 헥센올, 디메틸설파이드, 시클로텐, 푸르푸랄, 트리메틸피라진, 에틸락테이트, 에틸티오아세테이트 등의 단품 향료, 스트로베리 플레이버, 애플 플레이버, 바나나 플레이버, 파인애플 플레이버, 그레이프 플레이버, 망고 플레이버, 버터 플레이버, 밀크 플레이버, 후르츠믹스 플레이버, 트로피컬후르츠 플레이버 등의 조합 향료를 들 수 있고, 구강용 조성물에 사용되는 공지의 향료 소재를 조합시켜서 사용할 수 있지만, 실시예 기재의 향료에 한정되는 것은 아니다. 또한, 배합량도 특별히 한정되지 않지만, 상기 향료소재는 조성물 중에 0.000001∼1% 사용하는 것이 좋고, 향료 소재를 사용한 부향용 향료는, 제제 조성 중에 0.1∼2% 사용하는 것이 바람직하다.Flavors are peppermint oil, spearmint oil, anise oil, eucalyptus oil, wonter green oil, cassia oil, clove oil, thyme oil, sage oil, lemon oil, orange oil, mentha oil, cardamom oil, coriander oil, mandarin oil, lime oil, Lavender oil, rosemary oil, laurel milk, chamomile oil, caraway oil, marjoram oil, bay oil, lemongrass oil, duckweed oil, pine needle oil, neroli oil, rose oil, jasmine oil, grapefruit oil, sweetie oil, Natural fragrances such as citron oil, iris concrete, absolute peppermint, absolute rose, and orange flower, and processing treatment of these natural fragrances (current part cut, tail part cut, fractionation, liquid extraction, essence, powder fragrance Hwa, etc.), and menthol, carbon, anetol, cineol, methyl salicylate, cinnamic aldehyde, eugenol, 3-1-mentoxypropane-1,2-diol, thymol, linalool, linalyl Acetate, limonene, menthone, menthyl acetate, N-substituted-paramentane-3-carboxamide, pinene, octylaldehyde, citral, fullegon, carbyl acetate, anisaldehyde, ethyl acetate, ethyl butyrate, allylcyclohexane Propionate, methylanthranylate, ethylmethylphenylglycidate, vanillin, undecalactone, hexanal, butanol, isoamyl alcohol, hexenol, dimethylsulfide, cycloten, furfural, trimethylpyrazine, ethyl lactate, ethyl A la carte flavors such as thioacetate, strawberry flavor, apple flavor, banana flavor, pineapple flavor, grape flavor, mango flavor, butter flavor, milk flavor, fruit mix flavor, tropical fruit flavor, and other combination flavors can be mentioned. Although known fragrance materials used in the composition may be used in combination, it is not limited to the fragrances described in Examples. In addition, the blending amount is not particularly limited, but it is preferable to use 0.000001 to 1% of the perfume material in the composition, and 0.1 to 2% of the fragrance perfume using the perfume material in the formulation composition.
유효 성분은 치주 질환 관련의 약효 성분, 예를 들면 이소프로필메틸페놀, 염화벤잘코늄, 염화벤제토늄, 염화세틸피리디늄, 라우로일사르코신나트륨 등의 살균제, 비타민 E 등의 비타민류, 알란토인, 히노키티올, 글리시르레틴산, 글리시리진산 디칼륨, 염화나트륨, 질산 칼륨, 보리 등의 생약을 들 수 있다. 이들 임의의 유효 성분은 본 발명의 효과를 방해하지 않는 범위에서 유효량을 배합할 수 있다.Active ingredients include medicinal ingredients related to periodontal disease, such as isopropylmethylphenol, benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, sodium lauroylsarcosine, and other fungicides, vitamins such as vitamin E, allantoin, And herbal medicines such as hinokitiol, glycyrrhetinic acid, dipotassium glycyrrhizinate, sodium chloride, potassium nitrate, and barley. These optional active ingredients can be blended in an effective amount within a range that does not interfere with the effects of the present invention.
(실시예)(Example)
이하, 실시예 및 비교예를 나타내고, 본 발명을 구체적으로 설명하지만, 본 발명은 하기 실시예에 제한되는 것은 아니다. 또, 하기 예에 있어서 %는 특별히 언급하지 않는 한 모두 질량%를 나타낸다.Hereinafter, examples and comparative examples are shown, and the present invention is specifically described, but the present invention is not limited to the following examples. In addition, in the following examples, all represent% by mass unless otherwise specified.
[실시예, 비교예][Examples, Comparative Examples]
표 1∼3에 나타내는 조성의 치마제 조성물(치약)을 상법에 의해 조제하고, 하기 방법으로 평가했다. 결과를 표 1∼3에 병기했다. 표 중의 (B)성분량을 나타내는 수치는 사용 화합물 유래의 구리 또는 아연 이온량이다.The dentifrice composition (toothpaste) of the composition shown in Tables 1-3 was prepared by a conventional method, and evaluated by the following method. The results are also listed in Tables 1-3. The numerical value indicating the amount of the component (B) in the table is the amount of copper or zinc ions derived from the compound used.
또, 실시예의 치마제 조성물은 모두 항염증 효과를 갖고 있었다.Moreover, all of the dentifrice compositions of Examples had an anti-inflammatory effect.
<제제 변색(변색 없음)의 평가 방법><Evaluation method of formulation discoloration (no discoloration)>
치마제 조성물을 100g 충전용의 구경 8mm의 라미네이트 튜브 용기에 충전하고, 60℃에서 1개월간 보존했다. 또한, 동 조성의 치마제 조성물을 동일 용기에 충전하고 -5℃에서 1개월간 보존하여 비교용 표준품으로 했다. 각각을 보존 후에 튜브 용기로부터 압출했을 때의 변색 상태를 관찰하고, 표준품과 비교함으로써 하기 평가 기준으로 평가했다.The dentifrice composition was filled in a laminate tube container having a diameter of 8 mm for filling 100 g, and stored at 60°C for 1 month. Further, the dentifrice composition of the same composition was filled in the same container and stored at -5°C for 1 month to obtain a standard product for comparison. The discoloration state when each was extruded from a tube container after storage was observed, and evaluated by the following evaluation criteria by comparing with a standard product.
평가 기준Evaluation standard
◎: -5℃ 보존품(표준품)과 비교하여 변색이 확인되지 않는다◎: No discoloration is observed compared to -5℃ preserved products (standard products)
○: -5℃ 보존품(표준품)과 비교하여 변색이 거의 확인되지 않는다○: Almost no discoloration is observed compared to the -5°C storage product (standard product).
×: -5℃ 보존품(표준품)과 비교하여 변색이 확인된다×: Discoloration is confirmed compared with the -5°C preservation product (standard product).
<구취억제 효과 및 그 지속성의 평가 방법><Bad breath suppression effect and evaluation method of its persistence>
전문 패널리스트 5명으로 이루어지는 피험자에 의한 사용감 평가를 행했다. 칫솔(클리니카 어드벤티지 칫솔, 4열 컴팩트 보통 타입)에 치마제 조성물 1g을 묻혀, 3분간 양치를 행했다. 입안을 물로 양치하고, 헹굼 직후 및 헹구고 3시간 경과 후의 구취 실감에 대한 앙케이트를 실시하여, 하기 평점 기준으로 구취억제 효과(직후) 및 구취억제 효과의 지속성(3시간 경과 후)을 각각 판정했다. 5명의 평균점을 구하고, 하기 평가 기준으로 평가했다. 또, 구취억제 효과의 평가를 실시 중에는 음식을 금지했다.A feeling of use was evaluated by a test subject consisting of five expert panelists. A toothbrush (Clinica Advantage toothbrush, 4-row compact, normal type) was moistened with 1 g of the chima composition and brushed for 3 minutes. The mouth was rinsed with water, and a questionnaire was conducted on the feeling of bad breath immediately after rinsing and after 3 hours of rinsing, and the halitosis suppressing effect (immediately after) and the persistence of the halitosis suppressing effect (after 3 hours) were respectively determined based on the following score criteria. The average score of 5 people was calculated|required, and it evaluated by the following evaluation criteria. In addition, food was prohibited during the evaluation of the halitosis inhibitory effect.
평점 기준Rating criteria
5: 구취를 느끼지 않는다5: do not feel bad breath
4: 구취를 거의 느끼지 않는다4: I hardly feel bad breath
3: 구취를 약간 느끼지만 문제 없는 레벨3: A level with a little bad breath but no problem
2: 구취를 상당히 느낀다2: I feel bad breath considerably
1: 구취를 매우 느낀다1: I feel bad breath very much
평가 기준Evaluation standard
◎: 5명의 평균점이 4점 이상◎: Average score of 5 persons is 4 or more
○: 5명의 평균점이 3점 이상 4점 미만○: Average score of 5 persons is 3 or more and less than 4 points
×: 5명의 평균점이 3점 미만×: average score of 5 people is less than 3
질량수Mass number
글루콘산 구리: 453.84Copper gluconate: 453.84
염화아연: 136.29Zinc chloride: 136.29
산화아연: 81.408Zinc oxide: 81.408
구리 이온: 63.546Copper Ion: 63.546
아연 이온: 65.38Zinc Ion: 65.38
Claims (7)
(B) 구리 이온 또는 아연 이온, 및
(C) 모노플루오로인산 나트륨
을 함유하고, (C)성분의 함유량이 0.8∼3질량%인 구강용 조성물.(A) tranexamic acid or ε-aminocaproic acid,
(B) copper ions or zinc ions, and
(C) sodium monofluorophosphate
A composition for oral cavity containing, and the content of (C) component is 0.8-3 mass %.
(B) 구리 이온 또는 아연 이온의 공급원이, 25℃에 있어서의 수용해도가 5g/100mL 이상인 수용성의 구리 화합물 또는 아연 화합물인 구강용 조성물.The method of claim 1,
(B) An oral composition wherein the source of the copper ion or zinc ion is a water-soluble copper compound or zinc compound having a water solubility at 25°C of 5 g/100 mL or more.
(B) 구리 이온 또는 아연 이온의 공급원이 글루콘산 구리, 구리클로로필린나트륨, 염화아연 및 글루콘산 아연으로부터 선택되는 1종 또는 2종 이상의 수용성의 구리 화합물 또는 아연 화합물인 구강용 조성물.The method according to claim 1 or 2,
(B) An oral composition wherein the source of copper ions or zinc ions is one or two or more water-soluble copper compounds or zinc compounds selected from copper gluconate, sodium copper chlorophyllin, zinc chloride and zinc gluconate.
(B) 구리 이온 또는 아연 이온의 공급원이, 25℃에 있어서의 수용해도가 5g/100mL 미만인 수난용성 또는 수불용성의 구리 화합물 또는 아연 화합물의 산성수용액인 구강용 조성물.The method of claim 1,
(B) An oral composition wherein the source of copper ions or zinc ions is an acidic aqueous solution of a poorly water-soluble or water-insoluble copper compound or zinc compound having a water solubility at 25°C of less than 5 g/100 mL.
(A)성분을 0.006∼0.5질량%, (B)성분을 0.001∼0.1질량% 함유하는 구강용 조성물.The method according to any one of claims 1 to 4,
The composition for oral cavity containing 0.006 to 0.5 mass% of (A) component and 0.001 to 0.1 mass% of (B) component.
(C)/(B)가 질량비로서 10∼1,500인 구강용 조성물.The method according to any one of claims 1 to 5,
(C) / (B) is a composition for oral cavity of 10 to 1,500 as a mass ratio.
치마제 조성물인 구강용 조성물.The method according to any one of claims 1 to 6,
Oral composition, which is a dentifrice composition.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2018-091468 | 2018-05-10 | ||
JP2018091468 | 2018-05-10 | ||
PCT/JP2019/015814 WO2019216108A1 (en) | 2018-05-10 | 2019-04-11 | Oral composition |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210008828A true KR20210008828A (en) | 2021-01-25 |
Family
ID=68466956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020207020428A KR20210008828A (en) | 2018-05-10 | 2019-04-11 | Oral composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7236623B2 (en) |
KR (1) | KR20210008828A (en) |
CN (1) | CN111867554B (en) |
WO (1) | WO2019216108A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230040932A (en) * | 2021-09-15 | 2023-03-23 | 주식회사 엘지생활건강 | Composition for removing or improving oral malodor |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5842565B2 (en) | 1979-04-27 | 1983-09-20 | 株式会社 愛知電機工作所 | Switching switch for tap switching device on load |
JP2738021B2 (en) | 1989-05-26 | 1998-04-08 | ライオン株式会社 | Toothpaste composition |
JP2580657Y2 (en) | 1993-05-10 | 1998-09-10 | 株式会社東芝 | Water hammer prevention device for heater drain device |
JP3922329B2 (en) | 1998-11-27 | 2007-05-30 | ライオン株式会社 | Dentifrice composition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS595109A (en) * | 1982-06-30 | 1984-01-12 | Lion Corp | Composition for oral cavity |
JPH04139120A (en) * | 1990-09-27 | 1992-05-13 | Lion Corp | Composition for use in oral cavity |
JP2000319152A (en) * | 1999-05-12 | 2000-11-21 | Lion Corp | Dentifrice composition |
EP1698324A1 (en) * | 2004-11-09 | 2006-09-06 | The Procter & Gamble Company | Zinc-containing dentifrice compositions having an improved taste |
MX2010005130A (en) * | 2007-11-09 | 2010-08-04 | Procter & Gamble | Oral stannous compositions. |
CN104853727B (en) * | 2012-12-19 | 2018-04-20 | 高露洁-棕榄公司 | Oral care product comprising zinc oxide and trimethylglycine |
KR102518103B1 (en) * | 2015-02-26 | 2023-04-06 | 라이온 가부시키가이샤 | Toothpaste composition |
-
2019
- 2019-04-11 CN CN201980019431.3A patent/CN111867554B/en active Active
- 2019-04-11 JP JP2020518208A patent/JP7236623B2/en active Active
- 2019-04-11 KR KR1020207020428A patent/KR20210008828A/en not_active Application Discontinuation
- 2019-04-11 WO PCT/JP2019/015814 patent/WO2019216108A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5842565B2 (en) | 1979-04-27 | 1983-09-20 | 株式会社 愛知電機工作所 | Switching switch for tap switching device on load |
JP2738021B2 (en) | 1989-05-26 | 1998-04-08 | ライオン株式会社 | Toothpaste composition |
JP2580657Y2 (en) | 1993-05-10 | 1998-09-10 | 株式会社東芝 | Water hammer prevention device for heater drain device |
JP3922329B2 (en) | 1998-11-27 | 2007-05-30 | ライオン株式会社 | Dentifrice composition |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230040932A (en) * | 2021-09-15 | 2023-03-23 | 주식회사 엘지생활건강 | Composition for removing or improving oral malodor |
Also Published As
Publication number | Publication date |
---|---|
JP7236623B2 (en) | 2023-03-10 |
WO2019216108A1 (en) | 2019-11-14 |
JPWO2019216108A1 (en) | 2021-05-13 |
CN111867554A (en) | 2020-10-30 |
CN111867554B (en) | 2023-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5251350B2 (en) | Dentifrice composition | |
JP5381685B2 (en) | Dentifrice composition | |
JP6610561B2 (en) | Oral composition | |
JP7310357B2 (en) | oral composition | |
JP2008094772A (en) | Liquid composition for oral cavity | |
WO2019107338A1 (en) | Oral composition | |
JP2015117215A (en) | Dentifrice composition | |
JP7236623B2 (en) | oral composition | |
JP6911845B2 (en) | Oral composition | |
JP5948903B2 (en) | Dentifrice composition and method for improving antiseptic power of dentifrice composition | |
JP2009107988A (en) | Dentifrice composition | |
JP4158036B2 (en) | Dentifrice composition and method for producing the same | |
JP5825088B2 (en) | Liquid oral composition | |
JP7172028B2 (en) | oral composition | |
JP2012077032A (en) | Oral composition | |
JP6753142B2 (en) | Oral composition | |
KR20180133220A (en) | Oral composition | |
JP6614071B2 (en) | Liquid oral composition | |
CN116568269A (en) | Dentifrice composition | |
JP2024070036A (en) | Oral Composition | |
JP6617535B2 (en) | Dentifrice composition | |
KR20220035868A (en) | Compositions for oral use and agents for imparting massage sensation to the gums | |
JP2023087776A (en) | dentifrice composition | |
JP6439425B2 (en) | Liquid oral composition | |
JP2023083626A (en) | oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
WITB | Written withdrawal of application |